Howe & Rusling’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.3M | Buy |
95,814
+1,763
| +2% | +$169K | 0.54% | 57 |
|
|
2025
Q4 | $9.03M | Buy |
94,051
+28,624
| +44% | +$2.78M | 0.6% | 54 |
|
|
2025
Q3 | $6.23M | Buy |
65,427
+4,271
| +7% | +$393K | 0.43% | 66 |
|
|
2025
Q2 | $5.33M | Buy |
+61,156
| New | +$5.19M | 0.39% | 71 |
|
|
2022
Q4 | – | Sell |
-69,846
| Closed | -$5.64M | – | 737 |
|
|
2022
Q3 | $5.64M | Sell |
69,846
-2,792
| -4% | -$251K | 0.75% | 47 |
|
|
2022
Q2 | $6.52M | Buy |
72,638
+23,958
| +49% | +$2.43M | 0.83% | 43 |
|
|
2022
Q1 | $5.4M | Buy |
48,680
+26,473
| +119% | +$2.8M | 0.62% | 58 |
|
|
2021
Q4 | $2.3M | Sell |
22,207
-16,929
| -43% | -$1.96M | 0.27% | 84 |
|
|
2021
Q3 | $4.91M | Buy |
39,136
+38,941
| +19,970% | +$5.04M | 0.62% | 55 |
|
|
2021
Q2 | $24K | Buy |
195
+95
| +95% | +$11.9K | ﹤0.01% | 375 |
|
|
2021
Q1 | $12K | Sell |
100
-318
| -76% | -$37.3K | ﹤0.01% | 470 |
|
|
2020
Q4 | $49K | Sell |
418
-24
| -5% | -$2.64K | 0.01% | 281 |
|
|
2020
Q3 | $46K | Buy |
442
+63
| +17% | +$6.33K | 0.01% | 274 |
|
|
2020
Q2 | $35K | Buy |
379
+90
| +31% | +$8.63K | 0.01% | 293 |
|
|
2020
Q1 | $26K | Sell |
289
-6
| -2% | -$638 | 0.01% | 320 |
|
|
2019
Q4 | $33K | Sell |
295
-231
| -44% | -$25.3K | 0.01% | 334 |
|
|
2019
Q3 | $57K | Sell |
526
-2,085
| -80% | -$218K | 0.01% | 283 |
|
|
2019
Q2 | $254K | Sell |
2,611
-1,266
| -33% | -$116K | 0.04% | 169 |
|
|
2019
Q1 | $353K | Sell |
3,877
-1,863
| -32% | -$167K | 0.06% | 146 |
|
|
2018
Q4 | $522K | Sell |
5,740
-78,156
| -93% | -$7.3M | 0.11% | 114 |
|
|
2018
Q3 | $8.25M | Sell |
83,896
-316
| -0.4% | -$29.2K | 1.38% | 26 |
|
|
2018
Q2 | $7.21M | Buy |
84,212
+2,786
| +3% | +$233K | 1.3% | 30 |
|
|
2018
Q1 | $6.53M | Buy |
81,426
+6,152
| +8% | +$507K | 1.18% | 32 |
|
|
2017
Q4 | $6.08M | Sell |
75,274
-8,104
| -10% | -$649K | 1.1% | 30 |
|
|
2017
Q3 | $6.48M | Sell |
83,378
-657
| -0.8% | -$54.5K | 1.2% | 25 |
|
|
2017
Q2 | $7.46M | Buy |
84,035
+2,725
| +3% | +$230K | 1.52% | 19 |
|
|
2017
Q1 | $6.55M | Buy |
81,310
+30,470
| +60% | +$2.38M | 1.31% | 28 |
|
|
2016
Q4 | $3.62M | Sell |
50,840
-19,512
| -28% | -$1.53M | 0.79% | 51 |
|
|
2016
Q3 | $6.08M | Buy |
70,352
+69,898
| +15,396% | +$6.09M | 1.31% | 28 |
|
|
2016
Q2 | $39K | Buy |
454
+314
| +224% | +$25.4K | 0.01% | 262 |
|
|
2016
Q1 | $11K | Sell |
140
-1,294
| -90% | -$97.5K | ﹤0.01% | 509 |
|
|
2015
Q4 | $110K | Buy |
+1,434
| New | +$108K | 0.03% | 195 |
|
|
2015
Q2 | – | Sell |
-82
| Closed | -$6K | – | 1092 |
|
|
2015
Q1 | $6K | Buy |
+82
| New | +$6.21K | ﹤0.01% | 586 |
|
|
2014
Q3 | – | Sell |
-117
| Closed | -$7K | – | 919 |
|
|
2014
Q2 | $7K | Sell |
117
-116
| -50% | -$7.05K | ﹤0.01% | 560 |
|
|
2014
Q1 | $14K | Sell |
233
-33
| -12% | -$1.92K | ﹤0.01% | 508 |
|
|
2013
Q4 | $15K | Sell |
266
-32
| -11% | -$1.81K | ﹤0.01% | 431 |
|
|
2013
Q3 | $16K | Sell |
298
-51
| -15% | -$2.74K | 0.01% | 512 |
|
|
2013
Q2 | $18K | Buy |
+349
| New | +$17.3K | 0.01% | 509 |
|
Other funds holding MDT
VCM
VPM
Howe & Rusling's MDT Position: Q1 2026 in Review
Howe & Rusling increased its Medtronic (MDT) stake by 1.9% in Q1 2026, buying an estimated $169K and bringing the position to 95,814 shares worth $8.3M. The position accounts for 0.54% of the portfolio, ranked #57.
Howe & Rusling first reported a position in MDT in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.03M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Howe & Rusling held 95,814 shares of Medtronic worth $8.3M as of Q1 2026.
- Howe & Rusling bought 1,763 Medtronic shares in Q1 2026, an estimated $169K.
- Medtronic made up 0.54% of Howe & Rusling's portfolio in Q1 2026, its #57 holding.
- Howe & Rusling first reported a position in Medtronic in Q2 2013 and has held it in 38 quarters since.
- Howe & Rusling's Medtronic position peaked at $9.03M in Q4 2025.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.